Who is sponsoring NCT03652766?

NCT03652766 is sponsored by University of Minnesota.

What drugs are being tested in NCT03652766?

Interventions in NCT03652766: Daily Weight Tracking.

What condition does NCT03652766 study?

NCT03652766 studies Obesity Complicating Childbirth.

Is NCT03652766 still recruiting?

NCT03652766 is currently completed. Last updated 30 March 2020.

Last reviewed 2020-03-30 · How we verify

NCT03652766: PTRK

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pregnancy Weight Tracking Pilot Project

Completed NA Last updated 30 March 2020

What this trial tests

NA trial testing Daily Weight Tracking in Obesity Complicating Childbirth in 10 participants. Completed in 13 January 2020.

Timeline

7 January 2019

Primary endpoint
13 January 2020

13 January 2020

Quick facts

Lead sponsor	University of Minnesota
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	10
Start date	7 January 2019
Primary completion	13 January 2020
Estimated completion	13 January 2020
Sites	1 location across United States

Drugs / interventions tested

Daily Weight Tracking

Conditions studied

Obesity Complicating Childbirth — all drugs for Obesity Complicating Childbirth →

Sponsor

University of Minnesota

Who can join

Adults 18 to 35, female only, with Obesity Complicating Childbirth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot study will examine perceptions about daily weighing for pregnant women with overweight or obesity by testing the feasibility, acceptability, and preliminary efficacy of daily weighing for reducing excess gestational weight gain (GWG) within the context of a low intensity, digital-health based intervention delivered remotely with electronic feedback to participants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Minnesota trials

Trials by the same sponsor.

NCT02421497 — MRI Technical Development and Applications in Kidney Disease · not yet recruiting
NCT04100109 — Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic · NA · withdrawn
NCT05454306 — Anser Clavicle Pin for Surgical Management of Midshaft Clavicle Fractures · NA · withdrawn
NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
NCT04940533 — Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03652766 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Minnesota
Last refreshed: 30 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03652766.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing